SCHEMBL7091243

SCHEMBL7091243

Cc1ccc(S(=O)(=O)N[C@@H](c2ccccc2)[C@@H](NCl)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.54
ALDH1A1 P00352 5/20 0.54
CA12 O43570 4/20 0.50
CA9 Q16790 4/20 0.50
CA2 P00918 3/20 0.50
HTT P42858 2/20 0.50
CA1 P00915 1/20 0.50
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 3/20 0.48
MAPT P10636 2/20 0.48
CA7 P43166 1/20 0.48
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
GAA P10253 3/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6433794 1.00 NPSR1 (0.54) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL6005934 1.00 NPSR1 (0.54) NPSR1ALDH1A1CA12CA9CA2
Benzene SCHEMBL7095659 0.98 NPSR1 (0.53) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL7095133 0.94 NPSR1 (0.53) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL2068561 0.94 ALDH1A1 (0.59) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL607797 0.94 ALDH1A1 (0.59) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL2067591 0.94 ALDH1A1 (0.59) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL2068549 0.94 ALDH1A1 (0.59) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL7093232 0.89 MMP2 (0.47) NPSR1ALDH1A1CA12CA9CA2
SCHEMBL2242392 0.88 ALDH1A1 (0.54) NPSR1ALDH1A1CA12CA9CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030225289-A1 Process for the preparation of tricyclic amino alcohol derivatives ASAHI KASEI KABUSHIKI KAISHA (JP) 2003-12-04 US disclosed
EP-1209150-A1 PROCESSES FOR THE PREPARATION OF TRICYCLIC AMINO ALCOHOL DERIVATIVES Asahi Kasei Kabushiki Kaisha (JP) 2002-05-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225289-A1 Process for the preparation of tricyclic amino alcohol derivatives ADH1A, ADH1C, OXER1 NPSR1 755/4885ALDH1A1 80/4885CA12 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.